Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
141.7 EUR | -4.90% | -6.31% | -10.06% |
24/04 | IMCD's Spanish Unit to Buy Cobapharma | MT |
27/03 | IMCD's Benelux Arm to Purchase Gova Ingredients | MT |
Sales 2024 * | 4.73B 5.06B 0 | Sales 2025 * | 5.07B 5.42B 0 | Capitalization | 8.07B 8.62B 0 |
---|---|---|---|---|---|
Net income 2024 * | 305M 326M - | Net income 2025 * | 332M 355M - | EV / Sales 2024 * | 1.95 x |
Net Debt 2024 * | 1.15B 1.23B 0 | Net Debt 2025 * | 981M 1.05B 0 | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
26.7
x | P/E ratio 2025 * |
24.9
x | Employees | - |
Yield 2024 * |
1.6% | Yield 2025 * |
1.68% | Free-Float | 98.13% |
Latest transcript on IMCD N.V.
1 day | -4.90% | ||
1 week | -6.31% | ||
Current month | -13.25% | ||
1 month | -13.70% | ||
3 months | +0.14% | ||
6 months | +27.72% | ||
Current year | -10.06% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 30/20/30 | |
Hans Kooijmans
DFI | Director of Finance/CFO | 63 | 01/11/01 |
Marcus Jordan
COO | Chief Operating Officer | 50 | 01/98/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 09/18/09 | |
Amy Motto
BRD | Director/Board Member | 52 | 30/20/30 |
Willem Eelman
BRD | Director/Board Member | 60 | 02/22/02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.06% | 303 M€ | +12.60% | ||
0.37% | 18 M€ | +3.79% | - | |
0.21% | 2 M€ | +7.72% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 141.7 | -4.90% | 511,882 |
25/24/25 | 149 | -1.65% | 161,220 |
24/24/24 | 151.5 | -1.85% | 152,814 |
23/24/23 | 154.4 | +1.88% | 115,921 |
22/24/22 | 151.5 | +0.17% | 77,364 |
Real-time Euronext Amsterdam, April 26, 2024 at 09:05 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.06% | 8.61B | |
+25.96% | 1.01B | |
+8.23% | 173M | |
+36.99% | 143M | |
+4.24% | 115M | |
-4.88% | 99.64M | |
+7.15% | 87.9M |
- Stock Market
- Equities
- IMCD Stock